RxDoctor Payments Data

Jonathan Yun, MD

Neurological Surgery · Ridgewood, NJNPI 1467771279

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.5%), speaking fees and ownership interests — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Viseon, Inc. at 44.0% of the total. Reporting peaked in 2022 at $3,122 and has fallen 68.2% since, to $993 in 2025.

$9,008in general payments, 2019–2025

Across 81 payments — averaging $111.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viseon, Inc.$4K
  • Abbott$2K
  • Providence Medical Technology, Inc.$578
  • Medtronic$575
  • Globus Medical$446
  • Stryker$424
  • plus $1K from 13 others
$3,814in ownership & investment interests, 2019–2025

Across 4 payments — averaging $953.45 each. An ownership or investment interest held by the physician or an immediate family member.

  • Viseon, Inc.$4K

What the payments were for

  • Speaking & faculty fees$2,12524%
  • Travel & lodging$3574%
  • Food & beverage$4,45649%
  • Education$3204%
  • Ownership interest$1,75019%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,008 in reported general payments places this provider in the 70th percentile of 174 neurological surgery providers in New Jersey.

See all neurological surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$110,995
Medicare patients
190
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin21$248
Methylprednisolone23$127
Baclofen12$88
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$76

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Ridgewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →